Pramipexole

In the US, Pramipexole (pramipexole systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease, Periodic Limb Movement Disorder and Restless Legs Syndrome.

US matches:

• Pramipexole


• Pramipexole Extended-Release Tablets


• Pramipexole Dihydrochloride

UK matches:

• Pramipexole 0.088mg (SPC)
• Pramipexole 0.18mg (SPC)
• Pramipexole 0.7mg (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BC05

CAS registry number (Chemical Abstracts Service)

0104632-26-0

Chemical Formula

C10-H17-N3-S

Molecular Weight

211

Therapeutic Category

Treatment of Parkinson's disease: Dopaminergic

Chemical Name

2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N⁶-propyl-

Foreign Names

• Pramipexolum (Latin)
• Pramipexol (German)
• Pramipexole (French)
• Pramipexol (Spanish)

Generic Names

• Pramipexole (OS: DCF, USAN, BAN)
• SUD 919 CL 24 (IS)
• U 98528 E (IS: Upjohn)
• Pramipexole Hydrochloride (OS: BANM, USAN)
• PNU 98528 (IS: PharmaciaUpjoh)
• SND 919 Cl 2Y (IS: Boehringer Ingelheim)

Brand Names

• Apo-Pramipexole
  Apotex, Canada



• Mirapex
  Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Taiwan



• Mirapexin
  Boehringer Ingelheim, Spain



• Nixol
  Filaxis, Argentina



• Oprymea
  Krka, Luxembourg



• Pexola
  Boehringer Ingelheim, Turkey



• Portiv
  Buxton, Argentina



• Pramipex
  Sun, India



• Sifrol
  Boehringer Ingelheim, Malaysia



• BI Sifrol
  Boehringer Ingelheim, Japan



• BI-Sifrol
  Boehringer Ingelheim, Japan



• CO Pramipexole
  Cobalt, Canada



• Emwepel
  Stada, Slovakia



• Mirapex
  Boehringer Ingelheim, Canada; Boehringer Ingelheim, Russian Federation; Boehringer Ingelheim, United States



• Mirapexin
  Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim International, Luxembourg; Pfizer, Croatia (Hrvatska); Pfizer, Romania; Pfizer, Slovenia; Pharmacia, Serbia



• Pexola
  Boehringer Ingelheim, South Africa



• PMS-Pramipexole
  Pharmascience, Canada



• Pramipexole Dihydrochloride
  Teva USA, United States



• Pramipexol-Mepha
  Mepha Pharma, Switzerland



• Pramipexol-Teva
  Teva Pharma, Switzerland



• Sifrol BI
  Boehringer Ingelheim, Japan



• Sifrol
  Boehringer Ingelheim, United Arab Emirates; Boehringer Ingelheim, Argentina; Boehringer Ingelheim, Australia; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Bahrain; Boehringer Ingelheim, Brazil; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Chile; Boehringer Ingelheim, Cyprus; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Egypt; Boehringer Ingelheim, Finland; Boehringer Ingelheim, France; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Iraq; Boehringer Ingelheim, Iceland; Boehringer Ingelheim, Jordan; Boehringer Ingelheim, Kuwait; Boehringer Ingelheim, Lebanon; Boehringer Ingelheim, Libya; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, Oman; Boehringer Ingelheim, Qatar; Boehringer Ingelheim, Saudi Arabia; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Singapore; Boehringer Ingelheim, Thailand; Boehringer Ingelheim, Venezuela; Boehringer Ingelheim, Yemen; Boehringer Ingelheim International, Austria; Boehringer Ingelheim International, Luxembourg

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.